SCHEMBL6323130

SCHEMBL6323130

Cc1cc2c(C(N)c3cc(C(=N)NC(=O)c4ccccc4)ccc3OCc3ccccc3)ncnc2cc1C(=O)N1CCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
HPGD P15428 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
MAPT P10636 2/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
HSD17B10 Q99714 1/20 0.36
NMT1 P30419 1/20 0.36
MGLL Q99685 2/20 0.35
DPP7 Q9UHL4 1/20 0.35
ALDH1A1 P00352 3/20 0.34
ATM Q13315 1/20 0.34
PARP1 P09874 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
TP53 P04637 1/20 0.34
RECQL P46063 1/20 0.34
PDGFRB P09619 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6324410 0.92 HSD17B10 (0.38) NPC1RAB9AHPGDSMN1; SMN2MAPT
SCHEMBL6323858 0.90 HSD17B10 (0.34) NPC1RAB9AHPGDSMN1; SMN2MAPT
SCHEMBL6329304 0.90 HSD17B10 (0.39) NPC1RAB9AHPGDSMN1; SMN2MAPT
SCHEMBL6327108 0.88 KMT2A (0.34) NPC1RAB9AHPGDLMNAPOLB
SCHEMBL6332084 0.83 SLC6A9 (0.43) NPC1RAB9AHSD17B10NMT1SCN9A
SCHEMBL6323136 0.82 HPGD (0.38) NPC1RAB9AHPGDSMN1; SMN2MAPT
SCHEMBL6325599 0.82 HPGD (0.42) NPC1RAB9AHPGDSMN1; SMN2MAPT
SCHEMBL2989696 0.78 HPGD (0.37) NPC1RAB9AHPGDSMN1; SMN2MAPT
SCHEMBL3000533 0.77 HPGD (0.33) HPGDLMNAPOLBALDH1A1ATM
SCHEMBL2995879 0.77 F10 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050107409-A1 Aromatic bicyclic compounds, preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107409-A1 Aromatic bicyclic compounds, preparation thereof and their use as pharmaceutical compositions F12, F2, F11 NPC1 1892/4885RAB9A 1842/4885HPGD 1428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.